{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:48:02Z","timestamp":1788850082157,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jhep.2022.03.025","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T11:59:19Z","timestamp":1652702359000},"page":"1279-1290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Therapeutic advances in alcohol-associated hepatitis"],"prefix":"10.1016","volume":"76","author":[{"given":"Gyongyi","family":"Szabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8218-192X","authenticated-orcid":false,"given":"Mark","family":"Thursz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-573X","authenticated-orcid":false,"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2022.03.025_bib1","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.03.025_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"Management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.03.025_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jhep.2018.11.005","article-title":"Endpoints and patient stratification in clinical trials for alcoholic hepatitis","volume":"70","author":"Mathurin","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.03.025_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-020-0643-5","article-title":"Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits","volume":"23","author":"Zhou","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jhep.2022.03.025_bib6","article-title":"A\u00a0genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers","author":"Whitfield","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.03.025_bib7","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1038\/s41467-021-25392-y","article-title":"Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases","volume":"12","author":"Kapoor","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.03.025_bib8","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.03.025_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.03.025_bib10","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe\u00a0alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.32110","article-title":"Recovery and outcomes of patients denied early liver transplantation for severe alcohol-associated hepatitis","volume":"75","author":"Musto","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/apt.15376","article-title":"Systematic review with meta-analysis: high mortality in patients with non-severe alcoholic hepatitis","volume":"50","author":"Bennett","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2022.03.025_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/0962280214550759","article-title":"A\u00a0multi-stage drop-the-losers design for multi-arm clinical trials","volume":"26","author":"Wason","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jhep.2022.03.025_bib14","unstructured":"Trial R. Protocol: Randomized Evaluation Of Covid-19 Therapy (RECOVERY) 2021 [cited 12-19-2021]; Available from: www.recoverytrial.net."},{"key":"10.1016\/j.jhep.2022.03.025_bib15","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.03.025_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep4.1563","article-title":"Functionally diverse inflammatory responses in peripheral and liver monocytes in alcohol-associated hepatitis","volume":"4","author":"Kim","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2022.03.025_bib17","article-title":"Role of the inflammasome in liver disease","author":"de Carvalho Ribeiro","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jhep.2022.03.025_bib18","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2022.03.025_bib19","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.03.025_bib20","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.cct.2020.106094","article-title":"Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis","volume":"96","author":"Dasarathy","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jhep.2022.03.025_bib21","series-title":"Trial of anakinra (plus zinc) or prednisone in patients with severe alcoholic hepatitis (AlcHepNet)","year":"2019"},{"key":"10.1016\/j.jhep.2022.03.025_bib22","first-page":"144A","article-title":"IL-1 receptor antagonist in combination with pentoxifylline and zinc for severe alcoholic hepatitis: a multicenter randomized double-bind placebo-controlled clinical trial","volume":"68","author":"Szabo","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.30249","article-title":"Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice","volume":"69","author":"Ambade","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib24","doi-asserted-by":"crossref","first-page":"105922","DOI":"10.1016\/j.cct.2019.105922","article-title":"Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design","volume":"89","author":"Anstee","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jhep.2022.03.025_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31108","article-title":"Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study","volume":"72","author":"Ratziu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib26","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-021-24843-w","article-title":"Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.03.025_bib27","article-title":"Assessment and management of infection in alcoholic hepatitis","author":"Vergis","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2022.03.025_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.03.025_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/gutjnl-2015-310378","article-title":"Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase","volume":"66","author":"Vergis","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.03.025_bib30","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.03.025_bib31","first-page":"131","article-title":"PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury","author":"Triantafyllou","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2022.03.025_bib32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2018.07.005","article-title":"Abnormal neutrophil traps and impaired efferocytosis contribute to liver injury and sepsis severity after binge alcohol use","volume":"69","author":"Bukong","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.03.025_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/hep.31680","article-title":"Two faces of neutrophils in liver disease development and progression","volume":"74","author":"Cho","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib34","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.03.025_bib35","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1038\/s41598-017-07161-4","article-title":"Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2022.03.025_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cell.2013.03.026","article-title":"A\u00a0Direct in\u00a0vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration","volume":"153","author":"Wuestefeld","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2022.03.025_bib37","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/s41467-019-11004-3","article-title":"Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis","volume":"10","author":"Argemi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.03.025_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib40","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.jhepr.2020.100139","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Marot","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2022.03.025_bib41","doi-asserted-by":"crossref","first-page":"100220","DOI":"10.1016\/j.jhepr.2020.100220","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2022.03.025_bib42","article-title":"The fecal mycobiome in non-alcoholic fatty liver disease","author":"Demir","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.03.025_bib43","first-page":"381","article-title":"Update on the role of the gut microbiota on alcohol-associated liver disease","volume":"17","author":"Schnabl","year":"2021","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.jhep.2022.03.025_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib45","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.03.025_bib47","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.03.025_bib48","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A\u00a0randomized clinical trial of fecal microbiota transplant for alcohol use disorder","volume":"73","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib49","doi-asserted-by":"crossref","first-page":"1782157","DOI":"10.1080\/19490976.2020.1782157","article-title":"Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans","volume":"12","author":"Maccioni","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2022.03.025_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820942616","article-title":"Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention","volume":"13","author":"Skinner","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jhep.2022.03.025_bib51","doi-asserted-by":"crossref","first-page":"16169","DOI":"10.1038\/s41598-020-73149-2","article-title":"Transcutaneous fluorescence spectroscopy as a tool for non-invasive monitoring of gut function: first clinical experiences","volume":"10","author":"Maurice","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2022.03.025_bib52","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1089\/ars.2021.0005","article-title":"Targeting toll-like receptors in sepsis:\u00a0from bench to clinical trials","volume":"35","author":"Chen","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jhep.2022.03.025_bib53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cld.2021.04.001","article-title":"Genetic and environmental susceptibility to alcoholic hepatitis","volume":"25","author":"Morgan","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2022.03.025_bib54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.30996","article-title":"Genetic\u00a0variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers","volume":"72","author":"Stickel","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib55","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.03.025_bib56","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","article-title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model","volume":"75","author":"Yang","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.03.025_bib57","doi-asserted-by":"crossref","first-page":"100063","DOI":"10.1016\/j.jlr.2021.100063","article-title":"25-Hydroxycholesterol 3-sulfate is an endogenous ligand of DNA methyltransferases in hepatocytes","volume":"62","author":"Wang","year":"2021","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2022.03.025_bib58","first-page":"86a","article-title":"Combination of amoxicillin\/clavulanate and prednisolone in severe alcoholic hepatitis: results of the antibiocor randomized controlled trial","volume":"74","author":"Louvet","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.29080","article-title":"A\u00a0prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis","volume":"66","author":"Bissonnette","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib60","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.14309\/ajg.0000000000000912","article-title":"In severe alcoholic hepatitis, serum keratin-18 fragments are diagnostic, prognostic, and theragnostic biomarkers","volume":"115","author":"Atkinson","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2022.03.025_bib61","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/apt.15335","article-title":"Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis","volume":"50","author":"Forrest","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2022.03.025_bib62","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.30617","article-title":"Biomarkers of macrophage activation and immune danger signals predict\u00a0clinical outcomes in alcoholic hepatitis","volume":"70","author":"Saha","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.31256","article-title":"Circulating extracellular vesicles carrying sphingolipid cargo for the diagnosis and dynamic risk profiling of alcoholic hepatitis","volume":"73","author":"Sehrawat","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis","volume":"13","author":"Momen-Heravi","year":"2015","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jhep.2022.03.025_bib65","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/hep.31994","article-title":"Transcriptomic analysis reveals the MicroRNAs responsible for liver regeneration associated with mortality in alcohol-associated hepatitis","volume":"74","author":"Yang","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib66","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/hep.31603","article-title":"Application of artificial intelligence for the diagnosis and treatment of liver diseases","volume":"73","author":"Ahn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256428","article-title":"Predicting mortality among patients with liver cirrhosis in electronic health records with machine learning","volume":"16","author":"Guo","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2022.03.025_bib68","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mayocp.2021.10.026","article-title":"The mortality index for alcohol-associated hepatitis: a novel prognostic score","volume":"97","author":"Kezer","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2022.03.025_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2022.01.028","article-title":"Machine learning techniques differentiate alcohol-associated hepatitis from acute cholangitis in patients with systemic inflammation and elevated liver enzymes Mayo","author":"Ahn","year":"2022","journal-title":"Clin Proc"},{"key":"10.1016\/j.jhep.2022.03.025_bib70","series-title":"American Association for the Study of Liver Diseases Annual Meeting; 2020 November 13, 2020; Virtual","article-title":"Application of supervised machine learning techniques for classification of alcohol-associated hepatitis and acute cholangitis in patients with elevated liver enzymes and systemic inflammatory response","author":"Ahn","year":"2020"},{"key":"10.1016\/j.jhep.2022.03.025_bib71","article-title":"Effect of consumer-grade wearable device data on clinician decision making during post-discharge telephone calls after pediatric surgery","author":"Linton","year":"2021","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jhep.2022.03.025_bib72","article-title":"Development of the AI-Cirrhosis-ECG (ACE) Score: an electrocardiogram-based deep learning model in cirrhosis","author":"Ahn","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhep.2022.03.025_bib73","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.32329","article-title":"The digital transformation of hepatology: the patient is logged in","volume":"75","author":"Wu","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib74","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13063-018-2466-1","article-title":"Effects of automated smartphone mobile recovery support and telephone continuing care in the treatment of alcohol use disorder: study protocol for a randomized controlled trial","volume":"19","author":"McKay","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.jhep.2022.03.025_bib75","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/0929867324666171005111911","article-title":"Biomarkers of\u00a0alcohol consumption in body fluids - possibilities and limitations of application in toxicological analysis","volume":"26","author":"Wozniak","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jhep.2022.03.025_bib76","article-title":"Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American Association for the Study of Liver Diseases alcohol-associated liver disease special interest group","author":"Im","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.03.025_bib77","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.psym.2019.12.004","article-title":"Confronting the crisis of comorbid alcohol use disorder and alcohol-related liver disease with a novel multidisciplinary clinic","volume":"61","author":"Winder","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jhep.2022.03.025_bib78","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/hep.31235","article-title":"Integrated treatment of alcohol use disorder in patients with alcohol-associated liver disease: an evolving story","volume":"71","author":"Lucey","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.03.025_bib79","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2022.03.025_bib80","doi-asserted-by":"crossref","first-page":"108396","DOI":"10.1016\/j.jsat.2021.108396","article-title":"Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic","volume":"130","author":"Mellinger","year":"2021","journal-title":"J\u00a0Substance Abuse Treat"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822001994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822001994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:45:18Z","timestamp":1759175118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822001994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0168827822001994"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.03.025","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic advances in alcohol-associated hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}